Royal Bank of Canada’s Aethlon Medical AEMD Stock Holding History

Royal Bank of Canada’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	–	–	7058
2023 Q3	–	Hold	0	–	–	–	7029
2022 Q1	–	Sell	-3	Closed	-$5K	–	7700
2021 Q4	$5K	Hold	3	–	–	﹤0.01%	7210
2021 Q3	$10K	Hold	3	–	–	﹤0.01%	6947
2021 Q2	$12K	Hold	3	–	–	﹤0.01%	6794
2021 Q1	$5K	Buy	+3	New	+$5.77K	﹤0.01%	7025
2020 Q1	–	Hold	0	–	–	–	6615
2019 Q4	–	Hold	0	–	–	–	6774
2019 Q3	–	Hold	0	–	–	–	6647
2019 Q2	–	Hold	0	–	–	–	6824
2019 Q1	–	Hold	0	–	–	–	6763
2018 Q2	–	Hold	0	–	–	–	6478
2018 Q1	–	Hold	0	–	–	–	6294
2017 Q4	–	Hold	0	–	–	–	6496
2017 Q3	–	Hold	0	–	–	–	6673
2016 Q4	–	Hold	0	–	-$3K	–	6612
2016 Q3	–	Hold	0	–	–	–	6080
2016 Q2	–	Hold	0	–	–	–	5887
2016 Q1	–	Hold	0	–	–	–	5913
2015 Q4	–	Hold	0	–	–	–	6057
2015 Q3	–	Hold	0	–	–	–	6029

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Royal Bank of Canada's AEMD Position: Q4 2023 in Review

Royal Bank of Canada held its Aethlon Medical (AEMD) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7058.

Royal Bank of Canada first reported a position in AEMD in Q1 2021 and has held it in 4 quarters since. The position peaked at $12K in Q2 2021. 10 funds tracked by Wall St. Rank hold AEMD as of Q4 2023.

Royal Bank of Canada held 0 shares of Aethlon Medical worth $0 as of Q4 2023.
Royal Bank of Canada left its Aethlon Medical share count unchanged in Q4 2023.
Aethlon Medical made up ﹤0.01% of Royal Bank of Canada's portfolio in Q4 2023, its #7058 holding.
Royal Bank of Canada first reported a position in Aethlon Medical in Q1 2021 and has held it in 4 quarters since.
Royal Bank of Canada's Aethlon Medical position peaked at $12K in Q2 2021.
10 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.